[The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced Non-small-cell Lung Cancer.].
Zhang X, Xu L, Wang H, Zhu Y, Liu Z, Yue W, Tang J, Wu W, Liu Z, Wu Y, Zhang C, Shi Y, Wang M, Shi H, Li M, Meng Q, Guo L, Wang J, Li X.
Zhang X, et al. Among authors: meng q.
Zhongguo Fei Ai Za Zhi. 2008 Apr 20;11(2):206-13. doi: 10.3779/j.issn.1009-3419.2008.02.016.
Zhongguo Fei Ai Za Zhi. 2008.
PMID: 20731903
Free article.
Chinese.